Presentation is loading. Please wait.

Presentation is loading. Please wait.

Outcome of Purely Endoscopic Surgery for Pituitary Adenoma Orphee Makiese MD, Promod Pillai MD Venko Filipce MD, Mario Ammirati MD,MBA Dept. of Neurological.

Published byJosephine Powers Modified over 8 years ago

Similar presentations

Presentation on theme: "Outcome of Purely Endoscopic Surgery for Pituitary Adenoma Orphee Makiese MD, Promod Pillai MD Venko Filipce MD, Mario Ammirati MD,MBA Dept. of Neurological."— Presentation transcript:

1

2 Outcome of Purely Endoscopic Surgery for Pituitary Adenoma Orphee Makiese MD, Promod Pillai MD Venko Filipce MD, Mario Ammirati MD,MBA Dept. of Neurological Surgery Ohio State University Medical Center Columbus, OH NASBS-2008 A Systematic Literature Review

3 I. INTRODUCTION Applying new technology: a challenging change to surgical routines Applying new technology: a challenging change to surgical routines After feasibility study, using technology to treat patients requires strict follow-ups and comparisons with reference (s) technique (s) After feasibility study, using technology to treat patients requires strict follow-ups and comparisons with reference (s) technique (s) In order to fully and safely benefit patients In order to fully and safely benefit patients NASBS-2008

4 Over last decade, endoscopic used to assist trans-sphenoidal approaches Over last decade, endoscopic used to assist trans-sphenoidal approaches Review of the literature outcome of pure endoscopic assisted pituitary surgery Review of the literature outcome of pure endoscopic assisted pituitary surgery A Systematic Literature Review NASBS-2008 I. INTRODUCTION (Cont’d)

5 A Systematic Literature Review II. MATERIALS & METHODS Medline Pubmed (PM) data base (English) Medline Pubmed (PM) data base (English) Publications ranging from early 1990’s to 2007 Publications ranging from early 1990’s to 2007 Eligible studies all included outcome measurements Eligible studies all included outcome measurements NASBS-2008 A.Materials

6 A Systematic Literature Review Outcomes measurement of Outcomes measurement of Major and Major and Minor complications Minor complications Remission and recurrence rates evaluation Remission and recurrence rates evaluation Comparison to microscopic survey and systematic literature review Comparison to microscopic survey and systematic literature review NASBS-2008 B. Methods Objectives

7 A Systematic Literature Review C.Inclusion Criteria Purely endoscopic studies for pituitary adenoma (+10 patients) Purely endoscopic studies for pituitary adenoma (+10 patients) Adult pituitary surgery Adult pituitary surgery Trans-sphenoidal surgery (sub labial or nostril) Trans-sphenoidal surgery (sub labial or nostril) NASBS-2008

8 A Systematic Literature Review Diagnosis confirmed by MRI and endocrinology screening Diagnosis confirmed by MRI and endocrinology screening Histopathology-definite diagnosis of pituitary adenoma Histopathology-definite diagnosis of pituitary adenoma Studies including outcome measurements Studies including outcome measurements Follow-up more than 6 months Follow-up more than 6 months First surgery First surgery NASBS-2008 C. Inclusion Criteria (Cont’d)

9 A Systematic Literature Review D.Exclusion Criteria Following cases were disregarded… Following cases were disregarded… Recurrent pituitary tumors Recurrent pituitary tumors Subjects to previous endoscopic approach Subjects to previous endoscopic approach Submitted to prior radiation Submitted to prior radiation NASBS-2008

10 A Systematic Literature Review III.RESULTS 16 Articles: 16 Articles: 2 Class II 2 Class II 2 Class III 2 Class III 12 Class IV 12 Class IV From 105 articles “Pituitary and Endoscope Surgery’’, PM terms From 105 articles “Pituitary and Endoscope Surgery’’, PM terms Selection from a pool of 26617 articles on “Pituitary surgery” PM terms Selection from a pool of 26617 articles on “Pituitary surgery” PM terms NASBS-2008

11 A Systematic Literature Review 37.5% NA, 25% EU, 25% Asia, 12.5% ME 37.5% NA, 25% EU, 25% Asia, 12.5% ME 974 patients: 974 patients: 444 non functioning 444 non functioning 480 functioning 480 functioning 709 macro adenoma 709 macro adenoma 265 micro adenoma 265 micro adenoma Mean age=46 yrs; 51% female Mean age=46 yrs; 51% female NASBS-2008 III.RESULTS (Cont’d)

12 Identical methodology for microscopic group Identical methodology for microscopic group Statistical comparison of groups based on homogeneity and known epidemiologic pathology Statistical comparison of groups based on homogeneity and known epidemiologic pathology Assuming different surgeons and distinct population Assuming different surgeons and distinct population 16 articles for endoscopic group 974 16 articles for endoscopic group 974 16 articles for microscopic group 1971 16 articles for microscopic group 1971 NASBS-2008 A Systematic Literature Review III.RESULTS (Cont’d)

13 AuthorsYearType of StudyStudy Population Mean Age(Y)FHDuration of Study MacroMicro Jho H D and Carrau R L 1997Clinical, R4438(14-88)19251993-19963113 Sheehan MT et al1998Clinical, RC2659.2(25-80)8181995-1997260 ILan K et al1999Clinical, RC181996-1997126 Badie B et al1999Clinical, PC16 486101996-199997 Ogawa T et al2000Clinical, RC1349.1(19-73)671996-1999112 Cappabianca P et al2002Clinical, R14646.1(16-74)76681997-200112521 Cho D Y et al2002clinical, PC2245.3(22-60)2201996-200011 White D R et al2004Clinical, RC5041.126242000-2002 Kabil M S et al2005Clinical, RC30046(16-75)1761241998-200423565 Netea-Maier R T et al2006Clinical, R3541(14-68)25101998-2004629 Rudnik A et al2006Clinical, R6348.3(11-77)34292001-20025211 Kenan K et al2006Clinical, R7844.7(11-67)1997-20056711 Jain A.K. et al2007Clinical, P1040.16491 Dehdashiti AR et al2007Clinical, R25421962004 -2007718 Charalampaki P et al2007Clinical, R5056(28-84)30202004-2005419 Zhang X et al2007Clinical, R7845.1(15-76)42361998-20056711

14 AuthorsYearType of StudyStudy Population Mean Age(Y)FHDuration of Study MacroMicro Sheehan MT et al1998Clinical, RC4457.8(32-85)1331 1995-199744 Laws and Semple1999Clinical, R10538.5 (6-78)83221992-19971392 Zhang X et al1999Clinical, R20847.5(16-71)110981982-19971890 ILan K et al1999Clinical, RC201993-1995118 Badie B et al1999Clinical, PC214311101996-1999126 Ogawa T et al2000Clinical, RC1849.4(23-73)8101996-1999162 Kaltsas et al2001Clinical, R671993-19985017 Kreutzer et al2001Clinical, R5743.9(16-71)37201992-19983819 Rees D A et al2001Clinical, R5441.3(14-73)42121980-2000 Shimon I et al2002Clinical, R7439(8-72)64101990-2000371 Cho D Y et al2002Clinical, PC2246.7(18-56)2111996-20001012 DE P. et al2003Clinical, R4761(29-86)24231990-20013512 Höybye C et al2004Clinical, R3440(13-74)2681990-1999232 White D R et al2004Clinical, RC5043.517331996-1999 Mortini P et al2005Clinical, R114043(8-82)6814591990-200278872 Jain A.K. et al2007Clinical, PR1031.65582

15 A Systematic Literature Review A.Comparability: Sex, Age and Adenoma Size EndoscopeMicroscopeP-value Mean Age 46 44.60.6276 Sex 495F, 381M1189F, 795M0.0942 Macro adenoma 77%78%0.5168 Micro adenoma 23%22%0.5168 Functioning 52%77%0.0001 Nonfunctioning 48%33%0.0001 NASBS-2008

16 EndoscopeMicroscopeCiric National Survey 1997 Relative Risk P-value CSF 3.6%2.6%3.9%1.450.0736 Meningitis 0.71%0.2%1.5%3.480.0435 Sinusitis 1.9%0.3%8.5%6.340.0027 Vascular injury 1.3%0.57%1.1%2.380.0563 DI-Transient 5.6%8.1%0.680.0697 DI permanent 3.5%3.6%17.8%0.990.9632 Visual loss 1.7%0.36%1.4%4.880.0005 Major Complications 14.7%10.7%1.26 0.002 B.Major Complications and Comparisons NASBS-2008 A Systematic Literature Review

17 C.Minor Complications and Comparisons EndoscopeMicroscopeCiric National survey 1997Relative RiskP-value Epistaxis 0.72%0.26%3.4%2.720.1286 Septum perf 0.62%0.67%6.7%0.920.8583 Nerves injury 0%0.1%1.3% Anosmia 0.31%0% Crusting 0.62%0.21%3.00.1491 Synechia 0.52%0.36% 1.420.7689 Saddle nose 0%0.05% Minor complications 2.8% 2.3%1.1380.4955 NASBS-2008 A Systematic Literature Review

18 D.Length of Stay in Hospital EndoscopeMicroscopeP-value Length of stay in hospital 3.34 days6.1 days0.0984 too few values in micro gp NASBS-2008 A Systematic Literature Review

19 E.Death, Follow-up and Remission EndoscopeMicroscopeCiric National survey 1997Relative Risk P-value Death 0.6%0.4%0.9%1.440.73 Follow up 19.2 months 43.3 months Remission 65.2%65.3%0.9980.947726 Recurrence 0.1%4.2%0.0241.78*10 -10 too few values in endosc gp NASBS-2008 A Systematic Literature Review

20 CONCLUSIONS Two accurate observations that: Statistics seem SIGNIFICANT for microscope performed on major complications but… Statistics seem SIGNIFICANT for microscope performed on major complications but… NON SIGNIFICANT on minor complications NON SIGNIFICANT on minor complications NASBS-2008 A Systematic Literature Review A. Preliminary Remarks

21 Study accuracy would require more … Study accuracy would require more … Report data about length of stay in hospital for microscopic group Report data about length of stay in hospital for microscopic group Report data about recurrence and follow-up for endoscopic group Report data about recurrence and follow-up for endoscopic group Comparative studies to further meta-analysis study Comparative studies to further meta-analysis study NASBS-2008 A Systematic Literature Review B.Research recommendations

Download ppt "Outcome of Purely Endoscopic Surgery for Pituitary Adenoma Orphee Makiese MD, Promod Pillai MD Venko Filipce MD, Mario Ammirati MD,MBA Dept. of Neurological."

Similar presentations

Endoscopic and Combined Approaches Ruth E. Bristol, MD Assistant Professor of Neurosurgery.

Endoscopic and Combined Approaches Ruth E. Bristol, MD Assistant Professor of Neurosurgery.
Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.

Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.
Prolactin-secreting pituitary tumors Rosario Pivonello Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples,

Prolactin-secreting pituitary tumors Rosario Pivonello Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples,
Robotic-Assisted Thymectomy in Myasthenia Gravis Iskander Al-Githmi, MD, FRCSC, FRCSC (Ts&CDs), FACS, FCCP Department of Surgery. Division of Cardiothoracic.

Robotic-Assisted Thymectomy in Myasthenia Gravis Iskander Al-Githmi, MD, FRCSC, FRCSC (Ts&CDs), FACS, FCCP Department of Surgery. Division of Cardiothoracic.
Improving The Clinical Care of Children and Adolescents With Mild Traumatic Brain Injury Madeline Joseph, MD, FACEP, FAAP Professor of Emergency Medicine.

Improving The Clinical Care of Children and Adolescents With Mild Traumatic Brain Injury Madeline Joseph, MD, FACEP, FAAP Professor of Emergency Medicine.
Femoral neck fracture Speaker : 骨科 林愈鈞 Modular : 簡松雄 主任.

Femoral neck fracture Speaker : 骨科 林愈鈞 Modular : 簡松雄 主任.
Congenital Hip Dislocation.

Congenital Hip Dislocation.
Physician Compliance With the HEDS Recommendation of Antiviral Prophylaxis in Patients Diagnosed With Herpetic Stromal Keratitis at KEI Sameen Zaidi M.D.

Physician Compliance With the HEDS Recommendation of Antiviral Prophylaxis in Patients Diagnosed With Herpetic Stromal Keratitis at KEI Sameen Zaidi M.D.
Copyright restrictions may apply JAMA Facial Plastic Surgery Journal Club Slides: Patient-Reported Nasal Obstruction Scores Rhee JS, Sullivan CD, Frank.

Copyright restrictions may apply JAMA Facial Plastic Surgery Journal Club Slides: Patient-Reported Nasal Obstruction Scores Rhee JS, Sullivan CD, Frank.
ARTIFICIAL DISC VERSUS FUSION A prospective randomised study with 2-year follow-up on 99 patients.

ARTIFICIAL DISC VERSUS FUSION A prospective randomised study with 2-year follow-up on 99 patients.
Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.

Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus.
The 2004 ACEP Seizure Clinical Policy: The 2004 ACEP Seizure Clinical Policy: What About Pediatric Seizure and Status Epilepticus Patients? John M. Howell,

The 2004 ACEP Seizure Clinical Policy: The 2004 ACEP Seizure Clinical Policy: What About Pediatric Seizure and Status Epilepticus Patients? John M. Howell,
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.
The diabetic vascular foot (a 20 week snap shot review) Martin Arissol Vascular podiatrist.

The diabetic vascular foot (a 20 week snap shot review) Martin Arissol Vascular podiatrist.
E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.

E. McLaughlin, P. D. Chakravarty, D. Whittaker, E. Cowan, K. Xu, E. Byrne, D.M. Bruce, J. A. Ford University of Aberdeen.
As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,

As noted by Gary H. Lyman (JCO, 2012) “CER is an important framework for systematically identifying and summarizing the totality of evidence on the effectiveness,
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,

® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
The Effect of Zoledronic Acid (ZOL) on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole:

The Effect of Zoledronic Acid (ZOL) on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole:
Transsphenoidal Pituitary Tumors

Transsphenoidal Pituitary Tumors

Similar presentations

Ads by Google